A Journey Into Participation Patterns Among Patients With Hidradenitis Suppurativa

Power Life Sciences

Status: Begins enrollment in 5 months

Conditions: Hidradenitis Suppurativa

Study type: Observational

Funder types: Industry

Identifiers

NCT06201858

67172350

Details and patient eligibility

About

This study aims to uncover the factors driving patient decisions regarding enrollment, withdrawal, or re-engagement in hidradenitis suppurativa clinical trials. Understanding these factors will significantly improve the relevance and effectiveness of future research endeavors.

Ultimately, this trial endeavors to deepen our understanding of the factors impacting hidradenitis suppurativa clinical trial participation. Enhancing participation rates could accelerate the development of innovative treatments for this debilitating condition.

Enrollment: 500 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Aged ≥ 18 years old
• Diagnosis of hidradenitis suppurativa
• Able to comprehend the investigational nature of the protocol and provide informed consent

Exclusion criteria

• Female patients who are currently pregnant or nursing
• Inability to perform regular electronic reporting
• Has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial.

Trial design